Cargando…

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy

Genomic instability remains an enabling feature of cancer and promotes malignant transformation. Alterations of DNA damage response (DDR) pathways allow genomic instability, generate neoantigens, upregulate the expression of programmed death ligand 1 (PD-L1) and interact with signaling such as cycli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Minlin, Jia, Keyi, Wang, Lei, Li, Wei, Chen, Bin, Liu, Yu, Wang, Hao, Zhao, Sha, He, Yayi, Zhou, Caicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546664/ https://www.ncbi.nlm.nih.gov/pubmed/34729299 http://dx.doi.org/10.1016/j.apsb.2021.01.003

Ejemplares similares

Alterations of DNA damage repair in cancer: from mechanisms to applications
por: Jiang, Minlin, et al.
Publicado: (2020)

cGAS-STING, an important pathway in cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2020)

CD137, an attractive candidate for the immunotherapy of lung cancer
por: Ye, Lingyun, et al.
Publicado: (2020)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment
por: Wang, Hao, et al.
Publicado: (2019)

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
por: Deng, Juan, et al.
Publicado: (2019)

Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Guo, Haoyue, et al.
Publicado: (2021)

Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review
por: Li, Wei, et al.
Publicado: (2020)

Early diagnosis of lung cancer: which is the optimal choice?
por: Ning, Jing, et al.
Publicado: (2021)

Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
por: Guo, Haoyue, et al.
Publicado: (2020)

Immunotherapy as a treatment for small cell lung cancer: a case report and brief review
por: Wu, Yan, et al.
Publicado: (2020)

Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
por: Sun, Chenglong, et al.
Publicado: (2020)

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC
por: He, Yayi, et al.
Publicado: (2021)

Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes
por: Jiang, Tao, et al.
Publicado: (2020)

Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancer
por: Xu, Yi, et al.
Publicado: (2020)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure
por: Chen, Peixin, et al.
Publicado: (2020)

Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
por: Zhang, Huixian, et al.
Publicado: (2021)

The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review
por: Song, Xinyu, et al.
Publicado: (2021)

Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
por: Wang, Shixiang, et al.
Publicado: (2019)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

Distinct patterns of somatic genomic alterations and mutational signatures in central and peripheral-type small-cell lung cancer
por: Wang, Lei, et al.
Publicado: (2021)

Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19
por: Guo, Haoyue, et al.
Publicado: (2020)

Strategies for targeting the DNA damage response for cancer therapeutics
por: Zhang, Dan, et al.
Publicado: (2012)

Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
por: Chen, Yu, et al.
Publicado: (2021)

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
por: Brown, Jessica S, et al.
Publicado: (2018)

Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review
por: Cai, Yiyi, et al.
Publicado: (2021)

Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers
por: Jiang, Minlin, et al.
Publicado: (2020)

DNA Damage Repair in Brain Tumor Immunotherapy
por: Zhao, Shihong, et al.
Publicado: (2022)

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort
por: Zhang, Wenjing, et al.
Publicado: (2021)

sLAG-3 in non-small-cell lung cancer patients’ serum
por: He, Yayi, et al.
Publicado: (2018)

The DNA damage response in immunotherapy and radiation
por: Samstein, Robert M., et al.
Publicado: (2018)

The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
por: Liu, Yu, et al.
Publicado: (2021)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022)

Alteration of DNA Damage Response Causes Cleft Palate
por: Yamaguchi, Hiroyuki, et al.
Publicado: (2021)

Saturation Diving Alters Folate Status and Biomarkers of DNA Damage and Repair
por: Zwart, Sara R., et al.
Publicado: (2012)

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
por: Li, Bolei, et al.
Publicado: (2021)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gbcggeeps543u15j1l24o8p5tv